Product Liability

August 22, 2009

Yaz Lawsuit

Yaz and Yasmin are popular and widely-used oral contraceptives targeting women with the promises of worry free contraception. But there is potentially life threatening Yasmin side effects and Yaz side effects.Yaz was recently targeted by the Food and Drug Administration (FDA) as a prescription drug that is more dangerous and less effective than advertised by Bayer Healthcare Pharmaceuticals.

In mid-August 2009, the results of two new studies of oral contraceptives, including Yaz and Yasmin, were released in the British Medical Journal Online. The studies showed that Yaz, Yasmin and the generic form of Yaz, Ocella, caused a six-fold increase in the risk of blood clots, which cause injuries such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).

August 22, 2009

FDA Cracks Down on Ibuprofen Pain Relief Gels

by Dr. Shezad Malik

The Food and Drug Administration has issued warnings to eight companies for illegally marketing pain relief ointments containing ibuprofen.

Regulators said in a statement Thursday the companies do not have federal permission to market their products, which mix the popular pain relief drug with other ingredients. While ibuprofen is available in a variety of tablets like Advil, the FDA has not approved any ointments containing the drug.

“These companies have an obligation to demonstrate to the FDA that their products are safe and effective, and they have failed to do so,” said Deborah Autor, director of FDA’s office of compliance.

August 22, 2009

Yaz and Yasmin: Birth Control Pill Has Caused Patient Deaths, Heart Attack, and Stroke

by Dr. Shezad Malik

Yasmin is an oral contraceptive pill made by Bayer HealthCare Pharmaceuticals, Inc. that has been linked to heart attack, stroke, and blood clots in users. Women taking the drug to prevent pregnancy or to treat emotional and physical symptoms of PMDD (Premenstrual Dysphoric Disorder) and moderate acne have suffered severe injuries and even died as a result.

The drug has been linked to 50 or more deaths in the United States between 2004 and 2008 in addition to many other injuries. Bayer has been named in numerous lawsuits filed on behalf of women who were injured or died as a result of taking Yasmin.

Yasmin was approved by the Food and Drug Administration in 2006. A lower-dose version of the same drug, called Yaz, was approved in 2001. Yasmin is essentially the same drug as Yaz and uses a different kind of hormone than other birth-control pills, a drug called DRSP (drospirenone). DRSP has been shown to increase potassium in the body, which raises the possibility of severe health complications for women with kidney (renal) disease and cardiovascular conditions.

August 21, 2009

Diacetyl Induced Popcorn Workers Lung

by Dr. Shezad Malik

Dozens of workers around the country have developed the debilitating lung disease bronchiolitis obliterans, also known as “popcorn workers lung,” and other respiratory illnesses from exposure to vapors from diacetyl, a component of artificial butter flavor used in microwave popcorn and many other food products.

The National Institute for Occupational Safety and Health (NIOSH) conducted several studies that confirmed the link between occupational exposure to artificial butter flavoring and lung diseases. In 2000 they issued recommendations to a Missouri microwave popcorn plant about protecting workers from this hazard, and in 2003 they sent an alert recommending safeguards to 4,000 businesses that might use or make butter flavoring.

August 21, 2009

Avandia Risk of Heart Failure and Lawsuits

by Dr. Shezad Malik

If you believe you may have been harmed by the use of Avandia, it is important to note that your time to file a lawsuit against the maker of the drug could be running out. The statute of limitations in many states is coming up soon, and there still may be people who do not realize that the injury they have suffered could be related to their Avandia use.

New research shows that diabetics treated with the popular drug Avandia have higher risk of heart failure and death than those taking Actos, leading Canadian scientists to conclude that “continued use of [Avandia] may not be justified.”

The findings, published in today’s edition of the British Medical Journal, are the latest blow to the controversial blockbuster drug, manufactured by GlaxoSmithKline Inc.

Researchers stressed that the findings are relative and that Actos, a product of Takeda Pharmaceuticals North America Inc., also poses heart risks, albeit lesser ones.

August 21, 2009

Gadolinium Nephrogenic Systemic Fibrosis (MRI Dye) and Lawsuits

by Dr. Shezad Malik

A dye used in MRI (magnetic resonance imaging) and MRA (magnetic resonance angiography) scans has been linked to a rare and potentially fatal skin disease in some users.

The problem stems from the metal gadolinium found in the dyes injected into some patients before MRI scans and all patients before MRA scans.

The disease is known as nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD), and appears to only occur in patients with kidney disease who undergo an MRI or MRA where a gadolinium-based dye is used.

August 21, 2009

Yas/Yasmin JPML Hearing Set for September 24, 2009

by Dr. Shezad Malik

The Yasmin/Yaz lawyers at the Dr. Shezad Malik Law Firm are investigating potential Yasmin/Yaz lawsuits throughout the United States for claims on behalf of patients who took the drug and now suffer from deep vein thrombosis (blood clots in legs), pulmonary embolism, and/or strokes. Yasmin/Yaz have also been associated with heart attacks and death. These Yasmin/Yaz lawsuits allege product liability, negligence and failure to warn claims against Bayer Healthcare Pharmaceutical.

A MDL hearing has been set in the JPML Court in Richmond, Virginia on September 24, 2009.

August 21, 2009

Fleet Phospho Soda Side Effects and Lawsuits

by Dr. Shezad Malik

The Fleet Phospho-soda attorneys at Dr. Shezad Malik Law Firm are investigating potential lawsuits for individuals who have suffered severe kidney damage after a colonoscopy prep where Fleet Phospho-soda was used.

While most patients only became aware of the potential for Fleet Phospho-soda kidney problems when the product was recalled in December 2008, the manufacturer has been aware of the potential side effects for years.

August 21, 2009

Yasmin, YAZ, Ocella Birth Control Personal Injuries

by Dr. Shezad Malik

YAZ, also known as Yasmin or by its generic name Ocella is a birth control pill originally developed and manufactured by Berlex Laboratories, (a U.S affiliate of Schering AG).

YAZ, Yasmin, Ocella (drospirenone and ethinyl estradiol) is a combination birth control pill which contain two types of hormones: estrogen and a progestin. It is the only 24/4-day pill with the unique hormone, drospirenone (drsp) and its manufacturer claims that the product provides additional health benefits other then pregnancy prevention.

August 20, 2009

Fleet Phospho Soda and Kidney Damage

by Dr. Shezad Malik

Fleet Phospho Soda, a laxative product used for varying applications, was the subject of a December 2008 consumer alert from the FDA (the U.S. Food and Drug Administration). The alert warned that the use of phosphate-based laxatives such as Fleet Phospho Soda could result in kidney failure, even among individuals who do not have a medical condition that puts them at risk for kidney failure.

Fleet Phospho Soda is available without a prescription, it is a non-prescription laxative. It is widely used to clean the intestines before a colonoscopy and other medical procedures.

The Phospho Soda works by drawing fluid from the rest of the body into the colon; if an individual does not consume enough water or other fluids during Phospho Soda use, he or she may become dehydrated. The individual’s level of phosphate salts in the kidneys may also become too high — a development that can result in a type of kidney damage called acute phosphate nephropathy (APN).